Sign inJoin waitlistJoin the waitlist

Arun Rajan

Director, Medical Oncology Services · Clinical Center at the National Institutes of Health

Credentials: · ·

History

Thoracic and GI Malignancies Branch · Clinical Center at the National Institutes of Health
Present

Research

The Integrated Genomic Landscape of Thymic Epithelial Tumors
Cancer Cell · 2018 · 325 citations
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Review · Journal of Thoracic Oncology · 2022 · 293 citations
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
The Lancet Oncology · 2015 · 248 citations

GG
Giuseppe Giaccone
50 papers
AT
Anish Thomas
30 papers
ES
Eva Szabo
21 papers
James Gulley
16 papers
UG
Udayan Guha
15 papers
CC
Corey Carter
11 papers
William Figg
11 papers
Chul Kim
10 papers · 7 as a fellow
David Schrump
10 papers
RK
Ronan Kelly
9 papers · 5 as a fellow
Anja Roden
8 papers
Mark Raffeld
8 papers

Grants

Medical Oncology Service Clinical Core
National Cancer Institute · ZID
Contact PI · $13.6M · Division of Basic Sciences - Nci
Pilot Study of Avelumab in Thymic Epithelial Tumors
National Cancer Institute · ZIA
Contact PI · $2.9M · Division of Basic Sciences - Nci
Medical Oncology HIV-AIDS Clinical Research
National Cancer Institute · ZID
Contact PI · $2.4M · Division of Basic Sciences - Nci
A Phase II Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma
National Cancer Institute · ZIA
Contact PI · $1.5M · Division of Basic Sciences - Nci

Clinical trials

PT-112 in Subjects With Thymoma and Thymic Carcinoma
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2028
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2020–2027
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2019–2027
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2017–2028